Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Louie et al., Am J Health Syst Pharm 60 (4) 346-355.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LOUIE, S. G.
Right arrow Articles by YOON, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LOUIE, S. G.
Right arrow Articles by YOON, H.

Biological response modifiers in the management of rheumatoid arthritis

STAN G. LOUIE , BRIAN PARK , and HANNAH YOON


(February 15, 2003, Clinical Review). On page 346, the sentence beginning at the bottom of the first column of the Abstract should read, ``Newer therapeutic strategies for blocking the biological effects of inflammatory cytokines include antibodies directed against TNF (e.g., infliximab), soluble receptors (e.g., etanercept), and receptor antagonists to IL-1 (anakinra).''

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Health-System Pharmacists.